Pharmacological modulation of adrenergic tone alters the vasodilatory response to passive leg movement in young but not in old adults

Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors...

Full description

Saved in:
Bibliographic Details
Published inJournal of applied physiology (1985) Vol. 134; no. 5; pp. 1124 - 1134
Main Authors Fermoyle, Caitlin C., La Salle, D. Taylor, Alpenglow, Jeremy K., Craig, Jesse C., Jarrett, Catherine L., Broxterman, Ryan M., McKenzie, Alec I., Morgan, David E., Birgenheier, Nathaniel M., Wray, D. Walter, Richardson, Russell S., Trinity, Joel D.
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.05.2023
Subjects
Online AccessGet full text
ISSN8750-7587
1522-1601
1522-1601
DOI10.1152/japplphysiol.00682.2022

Cover

Loading…
Abstract Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α 1 -adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVC Δpeak ) and total vasodilation (LVC AUC , area under curve) were documented. PROP decreased LVC Δpeak (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg −1 , P < 0.001) and LVC AUC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg −1 , P = 0.002) in the young, but not in the old (LVC Δpeak , P = 0.931; LVC AUC , P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min −1 ·mmHg −1 , P < 0.01), LVC Δpeak (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min −1 ·mmHg −1 , P = 0.004), and LVC AUC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg −1 , P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVC Δpeak , P = 0.904; LVC AUC , P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVC Δpeak was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min −1 ·mmHg −1 , P = 0.004), and not in the old ( P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN – PE) of LVC Δpeak was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min −1 ·mmHg −1 , P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. NEW & NOTEWORTHY Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.
AbstractList Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α 1 -adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVC Δpeak ) and total vasodilation (LVC AUC , area under curve) were documented. PROP decreased LVC Δpeak (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg −1 , P < 0.001) and LVC AUC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg −1 , P = 0.002) in the young, but not in the old (LVC Δpeak , P = 0.931; LVC AUC , P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min −1 ·mmHg −1 , P < 0.01), LVC Δpeak (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min −1 ·mmHg −1 , P = 0.004), and LVC AUC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg −1 , P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVC Δpeak , P = 0.904; LVC AUC , P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVC Δpeak was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min −1 ·mmHg −1 , P = 0.004), and not in the old ( P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN – PE) of LVC Δpeak was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min −1 ·mmHg −1 , P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. NEW & NOTEWORTHY Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.
The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α 1 -adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVC Δpeak ) and total vasodilation (LVC AUC , area under curve) were documented. PROP decreased LVC Δpeak (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg −1 , P < 0.001) and LVC AUC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg −1 , P = 0.002) in the young, but not in the old (LVC Δpeak , P = 0.931; LVC AUC , P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min −1 ·mmHg −1 , P < 0.01), LVC Δpeak (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min −1 ·mmHg −1 , P = 0.004), and LVC AUC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg −1 , P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVC Δpeak , P = 0.904; LVC AUC , P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVC Δpeak was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min −1 ·mmHg −1 , P = 0.004), and not in the old ( P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN – PE) of LVC Δpeak was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min −1 ·mmHg −1 , P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. NEW & NOTEWORTHY Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.
The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α -adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVC ) and total vasodilation (LVC , area under curve) were documented. PROP decreased LVC (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg , < 0.001) and LVC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg , = 0.002) in the young, but not in the old (LVC , = 0.931; LVC , = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min ·mmHg , < 0.01), LVC (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min ·mmHg , = 0.004), and LVC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg , = 0.011) in the young, but not in the old (baseline LVC, = 0.199; LVC , = 0.904; LVC , = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: < 0.05), however LVC was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min ·mmHg , = 0.004), and not in the old ( = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN - PE) of LVC was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min ·mmHg , = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM. Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.
The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α1-adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVCΔpeak) and total vasodilation (LVCAUC, area under curve) were documented. PROP decreased LVCΔpeak (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg-1, P < 0.001) and LVCAUC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg-1, P = 0.002) in the young, but not in the old (LVCΔpeak, P = 0.931; LVCAUC, P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min-1·mmHg-1, P < 0.01), LVCΔpeak (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min-1·mmHg-1, P = 0.004), and LVCAUC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg-1, P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVCΔpeak, P = 0.904; LVCAUC, P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVCΔpeak was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min-1·mmHg-1, P = 0.004), and not in the old (P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN - PE) of LVCΔpeak was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min-1·mmHg-1, P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.NEW & NOTEWORTHY Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α1-adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVCΔpeak) and total vasodilation (LVCAUC, area under curve) were documented. PROP decreased LVCΔpeak (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg-1, P < 0.001) and LVCAUC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg-1, P = 0.002) in the young, but not in the old (LVCΔpeak, P = 0.931; LVCAUC, P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min-1·mmHg-1, P < 0.01), LVCΔpeak (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min-1·mmHg-1, P = 0.004), and LVCAUC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg-1, P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVCΔpeak, P = 0.904; LVCAUC, P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVCΔpeak was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min-1·mmHg-1, P = 0.004), and not in the old (P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN - PE) of LVCΔpeak was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min-1·mmHg-1, P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.NEW & NOTEWORTHY Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young. Systemic β-blockade attenuated the central hemodynamic component of the PLM response in young individuals. Inhibition of α-adrenergic receptors did not improve the PLM response in older individuals, though withdrawal of α-adrenergic modulation augmented baseline and maximal vasodilation in both groups. Accordingly, α-adrenergic signaling plays a role in modulating the PLM vasodilatory response in young but not in old adults, and elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.
The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However, the effect on passive leg movement (PLM)-induced LVC, a measure of vascular function, which is markedly attenuated in this population, is unknown. Thus, in eight young (25 ± 5 yr) and seven old (65 ± 7 yr) subjects, this investigation examined the impact of systemic β-adrenergic blockade (propanalol, PROP) alone, and PROP combined with either α1-adrenergic stimulation (phenylephrine, PE) or α-adrenergic inhibition (phentolamine, PHEN), on PLM-induced vasodilation. LVC, calculated from femoral artery blood flow and pressure, was determined and PLM-induced Δ peak (LVCΔpeak) and total vasodilation (LVCAUC, area under curve) were documented. PROP decreased LVCΔpeak (PROP: 4.8 ± 1.8, Saline: 7.7 ± 2.7 mL·mmHg−1, P < 0.001) and LVCAUC (PROP: 1.1 ± 0.7, Saline: 2.4 ± 1.6 mL·mmHg−1, P = 0.002) in the young, but not in the old (LVCΔpeak, P = 0.931; LVCAUC, P = 0.999). PE reduced baseline LVC (PE: 1.6 ± 0.4, PROP: 2.3 ± 0.4 mL·min−1·mmHg−1, P < 0.01), LVCΔpeak (PE: 3.2 ± 1.3, PROP: 4.8 ± 1.8 mL·min−1·mmHg−1, P = 0.004), and LVCAUC (PE: 0.5 ± 0.4, PROP: 1.1 ± 0.7 mL·mmHg−1, P = 0.011) in the young, but not in the old (baseline LVC, P = 0.199; LVCΔpeak, P = 0.904; LVCAUC, P = 0.823). PHEN increased LVC at rest and throughout PLM in both groups (drug effect: P < 0.05), however LVCΔpeak was only improved in the young (PHEN: 6.4 ± 3.1, PROP: 4.4 ± 1.5 mL·min−1·mmHg−1, P = 0.004), and not in the old (P = 0.904). Furthermore, the magnitude of α-adrenergic modulation (PHEN – PE) of LVCΔpeak was greater in the young compared with the old (Young: 3.35 ± 2.32, Old: 0.40 ± 1.59 mL·min−1·mmHg−1, P = 0.019). Therefore, elevated α-adrenergic tone does not appear to contribute to the attenuated vascular function with age identified by PLM.
Author Morgan, David E.
Broxterman, Ryan M.
Richardson, Russell S.
Trinity, Joel D.
Craig, Jesse C.
Birgenheier, Nathaniel M.
Wray, D. Walter
Fermoyle, Caitlin C.
Alpenglow, Jeremy K.
La Salle, D. Taylor
Jarrett, Catherine L.
McKenzie, Alec I.
Author_xml – sequence: 1
  givenname: Caitlin C.
  orcidid: 0000-0003-1027-7081
  surname: Fermoyle
  fullname: Fermoyle, Caitlin C.
  organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States
– sequence: 2
  givenname: D. Taylor
  surname: La Salle
  fullname: La Salle, D. Taylor
  organization: Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States
– sequence: 3
  givenname: Jeremy K.
  surname: Alpenglow
  fullname: Alpenglow, Jeremy K.
  organization: Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States
– sequence: 4
  givenname: Jesse C.
  orcidid: 0000-0001-5959-4139
  surname: Craig
  fullname: Craig, Jesse C.
  organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States
– sequence: 5
  givenname: Catherine L.
  orcidid: 0000-0001-5131-7858
  surname: Jarrett
  fullname: Jarrett, Catherine L.
  organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States
– sequence: 6
  givenname: Ryan M.
  orcidid: 0000-0002-7388-2214
  surname: Broxterman
  fullname: Broxterman, Ryan M.
  organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States, Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States
– sequence: 7
  givenname: Alec I.
  orcidid: 0000-0002-6336-8684
  surname: McKenzie
  fullname: McKenzie, Alec I.
  organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States
– sequence: 8
  givenname: David E.
  surname: Morgan
  fullname: Morgan, David E.
  organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States
– sequence: 9
  givenname: Nathaniel M.
  surname: Birgenheier
  fullname: Birgenheier, Nathaniel M.
  organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States
– sequence: 10
  givenname: D. Walter
  orcidid: 0000-0002-6907-1734
  surname: Wray
  fullname: Wray, D. Walter
  organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States, Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States
– sequence: 11
  givenname: Russell S.
  surname: Richardson
  fullname: Richardson, Russell S.
  organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States, Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States
– sequence: 12
  givenname: Joel D.
  orcidid: 0000-0001-8271-6536
  surname: Trinity
  fullname: Trinity, Joel D.
  organization: Division of Geriatrics, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States, Geriatric Research, Education, and Clinical Center, George E. Wahlen VA Medical Center, Salt Lake City, Utah, United States, Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, Utah, United States
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36927146$$D View this record in MEDLINE/PubMed
BookMark eNqFks1uEzEUhS3UiqaFVwBLbNhManv8M7NACFUtIFUqC1hbju1JHHnswfZEygPw3jhpqUo3XVny_e655-qec3ASYrAAvMdoiTEjl1s1TX7a7LOLfokQ78iSIEJegUWtkgZzhE_AohMMNYJ14gyc57xFCFPK8Gtw1vKeCEz5Avz5sVFpVDr6uHZaeThGM3tVXAwwDlCZZINNtQRLdQCVLzZlWDYW7lSOxlU0pj1MNk8xZFspOKmc3c5Cb9dVbWdHGwp0Ae7jHNZwNRcY4vEjelMHzL7kN-B0UD7btw_vBfh1c_3z6ltze_f1-9WX20ZTykujeluNG44oor3ighskCMdti4UhYhBC91j3rVGopWbghHFDWNtjuiKaWY3bC_D5XneaV6M1ujpLysspuVGlvYzKyf8rwW3kOu4kRpiwqloVPj4opPh7trnI0WVtvVfBxjlLIrqetILhw7APz9BtnFOo-0nSIcZIR7uuUu-eWnr08u9EFRD3gE4x52SHRwQjeQiDfBoGeQyDPIShdn561qldOZ627ub8i_1_AcxGwxM
CitedBy_id crossref_primary_10_14814_phy2_70180
Cites_doi 10.1113/jphysiol.2003.054650
10.1016/0735-1097(95)00327-4
10.1152/japplphysiol.00557.2017.-As
10.1152/ajpheart.00649.2019
10.1152/ajpregu.00345.2018
10.1111/j.1469-7793.2001.00977.x
10.1113/jphysiol.2012.240093
10.1007/s40279-019-01146-1
10.1016/s0735-1097(00)00849-4
10.1113/jphysiol.2011.212753
10.1152/ajpheart.01115.2010
10.1152/ajpheart.00784.2020
10.1152/ajpheart.00482.2010
10.1113/jphysiol.1978.sp012170
10.1152/ajpheart.00422.2015
10.1161/01.HYP.21.4.498
10.1152/ajpheart.00771.2005
10.1177/1358863X15586473
10.1161/01.CIR.100.2.164
10.1152/ajpheart.00240.2006
10.1152/ajpheart.01396.2006
10.1152/ajpheart.01016.2008
10.1152/japplphysiol.00979.2001
10.1152/ajpheart.00806.2014
10.1113/EP089818
10.1113/EP089629
10.1113/JP273183
10.1152/japplphysiol.01120.2013
10.1161/CIRCULATIONAHA.110.953653
10.1113/jphysiol.2014.278358
10.1249/MSS.0000000000000782
10.1161/HYPERTENSIONAHA.119.12881
10.1113/JP270195
10.1161/01.CIR.0000028819.64790.BE
10.1152/ajpheart.00886.2015
10.1152/japplphysiol.00452.2021
10.1016/j.autneu.2022.102969
10.1113/jphysiol.2003.042747
10.1113/JP270946
10.1016/S0735-1097(01)01786-7
10.1152/japplphysiol.00110.2014
10.1161/01.HYP.32.1.9
10.1016/0735-1097(94)90627-0
10.1113/jphysiol.2010.198770
10.1161/01.HYP.32.2.298
10.1113/jphysiol.2011.224741
10.1152/ajpheart.00038.2011
ContentType Journal Article
Copyright Copyright American Physiological Society May 2023
Published by the American Physiological Society
Copyright_xml – notice: Copyright American Physiological Society May 2023
– notice: Published by the American Physiological Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TK
7TS
7U7
8FD
C1K
FR3
P64
7X8
5PM
DOI 10.1152/japplphysiol.00682.2022
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Physical Education Index
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
Toxicology Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Physical Education Index
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE
MEDLINE - Academic
Technology Research Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
DocumentTitleAlternate PASSIVE LEG MOVEMENT AND ADRENERGIC TONE WITH AGE
EISSN 1522-1601
EndPage 1134
ExternalDocumentID PMC10125034
36927146
10_1152_japplphysiol_00682_2022
Genre Research Support, U.S. Gov't, Non-P.H.S
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: CSRD VA
  grantid: I01 CX001999
– fundername: NHLBI NIH HHS
  grantid: R01 HL142603
– fundername: NHLBI NIH HHS
  grantid: T32 HL007576
– fundername: RRD VA
  grantid: IK2 RX001215
– fundername: CSRD VA
  grantid: I01 CX002152
– fundername: NHLBI NIH HHS
  grantid: T32 HL139451
– fundername: ;
  grantid: T32 HL139451
– fundername: ;
  grantid: E9275-L
– fundername: ;
  grantid: I01CX001999
– fundername: ;
  grantid: R01HL142603
– fundername: ;
  grantid: Advanced Fellowship in Geriatrics
GroupedDBID ---
-~X
.55
18M
29J
2WC
4.4
53G
5VS
85S
AAFWJ
AAYXX
ABCQX
ABDNZ
ABHWK
ABJNI
ABKWE
ABOCM
ACBEA
ACGFO
ACGFS
ACIWK
ACPRK
ADBBV
ADFNX
AEILP
AENEX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKKCC
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
EMOBN
F5P
FRP
GX1
H13
H~9
ITBOX
KQ8
L7B
OK1
P2P
P6G
PQQKQ
RAP
RHI
RPL
RPRKH
SJN
TR2
UHB
UKR
UPT
W8F
WH7
WOQ
X7M
XSW
YBH
YQT
YWH
~02
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TK
7TS
7U7
8FD
C1K
FR3
P64
7X8
5PM
ID FETCH-LOGICAL-c446t-a9e692d604049a676d072613317d27f77c91c93da034df6256d253914b2c5ec13
ISSN 8750-7587
1522-1601
IngestDate Thu Aug 21 18:34:29 EDT 2025
Fri Sep 05 14:08:06 EDT 2025
Mon Jun 30 10:43:57 EDT 2025
Thu Apr 03 06:57:07 EDT 2025
Tue Jul 01 03:17:04 EDT 2025
Thu Apr 24 23:11:09 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords blood flow regulation
vascular function
vascular aging
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c446t-a9e692d604049a676d072613317d27f77c91c93da034df6256d253914b2c5ec13
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-1027-7081
0000-0002-6336-8684
0000-0001-5959-4139
0000-0002-7388-2214
0000-0001-5131-7858
0000-0002-6907-1734
0000-0001-8271-6536
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/10125034
PMID 36927146
PQID 2805528488
PQPubID 40905
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10125034
proquest_miscellaneous_2789237511
proquest_journals_2805528488
pubmed_primary_36927146
crossref_primary_10_1152_japplphysiol_00682_2022
crossref_citationtrail_10_1152_japplphysiol_00682_2022
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-05-01
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 05
  year: 2023
  text: 2023-05-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda
– name: Rockville, MD
PublicationTitle Journal of applied physiology (1985)
PublicationTitleAlternate J Appl Physiol (1985)
PublicationYear 2023
Publisher American Physiological Society
Publisher_xml – name: American Physiological Society
References B20
B42
B21
B43
B22
B44
B23
B45
B24
B46
B25
B47
B26
B48
B27
B28
B29
B30
B31
B10
B32
B11
B33
B12
B34
B13
B35
B14
B36
B15
B37
B16
B38
B17
B39
B18
B19
B1
B2
B3
B4
B5
B6
B7
B9
B40
B41
References_xml – ident: B27
  doi: 10.1113/jphysiol.2003.054650
– ident: B9
  doi: 10.1016/0735-1097(95)00327-4
– ident: B25
  doi: 10.1152/japplphysiol.00557.2017.-As
– ident: B40
  doi: 10.1152/ajpheart.00649.2019
– ident: B28
  doi: 10.1152/ajpregu.00345.2018
– ident: B3
  doi: 10.1111/j.1469-7793.2001.00977.x
– ident: B5
  doi: 10.1113/jphysiol.2012.240093
– ident: B33
  doi: 10.1007/s40279-019-01146-1
– ident: B35
  doi: 10.1016/s0735-1097(00)00849-4
– ident: B34
  doi: 10.1113/jphysiol.2011.212753
– ident: B6
  doi: 10.1152/ajpheart.01115.2010
– ident: B18
  doi: 10.1152/ajpheart.00784.2020
– ident: B31
  doi: 10.1152/ajpheart.00482.2010
– ident: B43
  doi: 10.1113/jphysiol.1978.sp012170
– ident: B29
  doi: 10.1152/ajpheart.00422.2015
– ident: B42
  doi: 10.1161/01.HYP.21.4.498
– ident: B38
  doi: 10.1152/ajpheart.00771.2005
– ident: B39
  doi: 10.1177/1358863X15586473
– ident: B2
  doi: 10.1161/01.CIR.100.2.164
– ident: B16
  doi: 10.1152/ajpheart.00240.2006
– ident: B23
  doi: 10.1152/ajpheart.01396.2006
– ident: B44
  doi: 10.1152/ajpheart.01016.2008
– ident: B41
  doi: 10.1152/japplphysiol.00979.2001
– ident: B19
  doi: 10.1152/ajpheart.00806.2014
– ident: B46
  doi: 10.1113/EP089818
– ident: B24
  doi: 10.1113/EP089629
– ident: B37
  doi: 10.1113/JP273183
– ident: B22
  doi: 10.1152/japplphysiol.01120.2013
– ident: B7
  doi: 10.1161/CIRCULATIONAHA.110.953653
– ident: B45
  doi: 10.1113/jphysiol.2014.278358
– ident: B21
  doi: 10.1249/MSS.0000000000000782
– ident: B12
  doi: 10.1161/HYPERTENSIONAHA.119.12881
– ident: B47
  doi: 10.1113/JP270195
– ident: B30
  doi: 10.1161/01.CIR.0000028819.64790.BE
– ident: B36
  doi: 10.1152/ajpheart.00886.2015
– ident: B48
  doi: 10.1152/japplphysiol.00452.2021
– ident: B20
  doi: 10.1016/j.autneu.2022.102969
– ident: B4
  doi: 10.1113/jphysiol.2003.042747
– ident: B13
  doi: 10.1113/JP270946
– ident: B15
  doi: 10.1016/S0735-1097(01)01786-7
– ident: B14
  doi: 10.1152/japplphysiol.00110.2014
– ident: B11
  doi: 10.1161/01.HYP.32.1.9
– ident: B10
  doi: 10.1016/0735-1097(94)90627-0
– ident: B26
  doi: 10.1113/jphysiol.2010.198770
– ident: B1
  doi: 10.1161/01.HYP.32.2.298
– ident: B17
  doi: 10.1113/jphysiol.2011.224741
– ident: B32
  doi: 10.1152/ajpheart.00038.2011
SSID ssj0014451
Score 2.4211636
Snippet Stimulation of α1-adrenergic receptors eliminated age-related differences in passive leg movement (PLM) by decreasing PLM-induced vasodilation in the young....
The age-related increase in α-adrenergic tone may contribute to decreased leg vascular conductance (LVC) both at rest and during exercise in the old. However,...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1124
SubjectTerms Adrenergic Agents - pharmacology
Aged
Blood flow
Blood pressure
Femoral artery
Hemodynamics
Humans
Leg
Leg - blood supply
Modulation
Movement - physiology
Phentolamine
Phenylephrine
Regional Blood Flow - physiology
Vasodilation
Vasodilation - physiology
Title Pharmacological modulation of adrenergic tone alters the vasodilatory response to passive leg movement in young but not in old adults
URI https://www.ncbi.nlm.nih.gov/pubmed/36927146
https://www.proquest.com/docview/2805528488
https://www.proquest.com/docview/2789237511
https://pubmed.ncbi.nlm.nih.gov/PMC10125034
Volume 134
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAvCDYuhYGMhHiJCrk4dvI4VSvTNMYkWqlvkZO4o1KWVL1M6t75NfxJzrGdNB2dGLxErXOVz5eTc-zP3yHkg4oDNgHX2PNDiaNVUd5LPZnB6y6yPGUqhQ2yLc75yYidjsNxp_OrxVpaLdNP2c3OdSX_Y1VoA7viKtl_sGxzUWiA32Bf2IKFYXsvG19sdKd1X19Vua3GZab3Ua5yDrscVNx29MT4Qkea13JR5dPCzLDPDU1W19CYQSyNXKJCXcLVtJa4riGwRqfgpKulU1a6oSpyo92xuCO8lTa81UMnRugJNaHiKGwNPgzgu1CtDaO5jyV8cA1iwxGSznes9KLdomOGFhp8FjNVXhZmYupUzXFRTDNg25_LqeEZozC6vaAd2fBbPMLaGUOi7HHbpHa01R7cjodO25Pk2h9DNMl2fyhCXxcogL6w_YAMvwiX5pl10tvS3OffksHo7CwZHo-HD8hDXwjNCfgybvhEHiq9aXFe-4CWTAj_P99xm-1Q6I_85jZNtxX3DJ-SJ9ai9Mig7xnpqHKfHByVgJ2rNf1ILxr77pNHXy1T44D8vIVNusEmrSZ0g02K2KQGmxSwSdvYpDU24ShqsUkBm7TGJp2WVGOTAjYpYBMbAJvUYPM5GQ2Oh_2Tni350csY48uejBWP_ZzDp4XFkgueuwJy_ABcR-6LiRBZ7GVxkEs3YPkEcnee-2EQeyz1s1BlXvCC7JXw2K8IlUEgM0heeBZxxiVEXRJSI-G6iqdMiLhLeN37SWb18LEsS5HovDj0k7bZEm22BM3WJW5z4sxIwvz9lMPavIn1H4vEj9wwhOgwirrkfbMbvDtO2clSVSs4RkSQgQnIirrkpUFDc88AekpAoNMl0RZOmgNQOX57Tzn9oRXkUdQvhC58fY8bvyGPNy_nIdlbzlfqLQTiy_SdfgF-A8525tc
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pharmacological+modulation+of+adrenergic+tone+alters+the+vasodilatory+response+to+passive+leg+movement+in+young+but+not+in+old+adults&rft.jtitle=Journal+of+applied+physiology+%281985%29&rft.au=Fermoyle%2C+Caitlin+C&rft.au=La+Salle%2C+D+Taylor&rft.au=Alpenglow%2C+Jeremy+K&rft.au=Craig%2C+Jesse+C&rft.date=2023-05-01&rft.issn=1522-1601&rft.eissn=1522-1601&rft.volume=134&rft.issue=5&rft.spage=1124&rft_id=info:doi/10.1152%2Fjapplphysiol.00682.2022&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8750-7587&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8750-7587&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8750-7587&client=summon